Fate Therapeutics (FATE) Earnings
|
Expand Research on FATE
| Next EPS Date | 7/30/26 *Est. | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +10.7% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | +6.3% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/6/26  |
Q126 | N/A | -$0.28 | N/A | N/A | $1.18M | N/A | N/A | N/A | ||
| 3/2/26 |
Q425 | N/A | -$0.27 | N/A | N/A | $1.25M | N/A | N/A | N/A | ||
| 11/13/25 | Q325 | -$0.27 | -$0.30 | +$0.03 | $1.74M | $1.36M | N/A |  | | Details | |
| 11/12/25 |
Q325 | N/A | -$0.30 | N/A | N/A | $1.36M | N/A | N/A | N/A | ||
| 11/11/25 |
Q325 | N/A | -$0.30 | N/A | N/A | $1.36M | N/A | N/A | N/A | ||
| 11/10/25 |
Q325 | N/A | -$0.30 | N/A | N/A | $1.36M | N/A | N/A | N/A | ||
| 11/7/25 |
Q325 | N/A | -$0.30 | N/A | N/A | $1.36M | N/A | N/A | N/A | ||
| 11/5/25 |
Q325 | N/A | -$0.30 | N/A | N/A | $1.36M | N/A | N/A | N/A |
